Compare ALRM & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALRM | CDNA |
|---|---|---|
| Founded | 2000 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.3B |
| IPO Year | 2015 | 2007 |
| Metric | ALRM | CDNA |
|---|---|---|
| Price | $66.73 | $72.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 8 |
| Target Price | $73.00 | ★ $94.43 |
| AVG Volume (30 Days) | 478.5K | ★ 1.2M |
| Earning Date | 11-05-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.42 | N/A |
| EPS | 1.61 | ★ 2.45 |
| Revenue | ★ $1,011,187,000.00 | $48,324,000.00 |
| Revenue This Year | $9.42 | $38.18 |
| Revenue Next Year | $6.86 | $8.98 |
| P/E Ratio | $41.29 | ★ $30.40 |
| Revenue Growth | 7.59 | ★ 18.93 |
| 52 Week Low | $41.49 | $15.56 |
| 52 Week High | $69.40 | $90.87 |
| Indicator | ALRM | CDNA |
|---|---|---|
| Relative Strength Index (RSI) | 65.64 | 47.70 |
| Support Level | $63.66 | $17.15 |
| Resistance Level | $69.40 | $90.87 |
| Average True Range (ATR) | 1.98 | 5.28 |
| MACD | -0.27 | -1.59 |
| Stochastic Oscillator | 53.44 | 3.71 |
Alarm.com Holdings Inc has a cloud-based platform that offers an expansive suite of IoT solutions addressing world-wide opportunities in the residential, multi-family, small business and enterprise commercial markets. It has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected device.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.